tiprankstipranks
Abbott Laboratories (GB:0Q15)
LSE:0Q15
Holding GB:0Q15?
Track your performance easily

Abbott Laboratories (0Q15) Income Statement

2 Followers

Abbott Laboratories Income Statement

Last quarter (Q3 2024), Abbott Laboratories's total revenue was $10.63B, an increase of 4.85% from the same quarter last year. In Q3, Abbott Laboratories's net income was $1.65B. See Abbott Laboratories’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 41.22B$ 40.11B$ 43.65B$ 43.08B$ 34.61B$ 31.90B
Cost of Revenue
$ 18.32B$ 17.98B$ 19.14B$ 18.54B$ 15.00B$ 13.23B
Gross Profit
$ 22.90B$ 22.13B$ 24.51B$ 24.54B$ 19.61B$ 18.67B
Operating Expense
$ 16.20B$ 15.66B$ 16.15B$ 16.11B$ 12.12B$ 12.21B
Operating Income
$ 6.69B$ 6.48B$ 8.36B$ 8.43B$ 5.36B$ 4.53B
Net Non Operating Interest Income Expense
$ 42.00M$ -252.00M$ -375.00M$ -490.00M$ -500.00M$ -576.00M
Other Income Expense
$ 586.00M$ 438.00M$ 319.00M$ -277.00M$ -103.00M$ -128.00M
Pretax Income
$ 6.78B$ 6.66B$ 8.31B$ 8.21B$ 4.97B$ 4.08B
Tax Provision
$ 1.01B$ 941.00M$ 1.37B$ 1.14B$ 497.00M$ 390.00M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 5.77B$ 5.72B$ 6.93B$ 7.07B$ 4.50B$ 7.56B
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 34.52B$ 33.63B$ 35.29B$ 34.65B$ 27.12B$ 25.44B
Net Income From Continuing And Discontinued Operation
$ 5.77B$ 5.72B$ 6.93B$ 7.07B$ 4.50B$ 3.69B
Normalized Income
$ 6.43B$ 5.31B--$ 3.96B$ 3.29B
Interest Expense
------
EBIT
$ 7.36B$ 7.30B$ 8.86B$ 8.74B$ 5.51B$ 4.75B
EBITDA
$ 10.58B$ 10.54B$ 12.13B$ 12.28B$ 8.84B$ 7.76B
Currency in USD

Abbott Laboratories Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis